Comparison of ibritumomab tiuxetan with rituximab, both in combination with BEAM conditioning therapy, in patients with mantle cell lymphoma prior to stem cell transplantation
Latest Information Update: 15 Feb 2017
At a glance
- Drugs Ibritumomab tiuxetan (Primary) ; Carmustine; Cytarabine; Etoposide; Melphalan; Rituximab
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
- 15 Feb 2017 New trial record